TCTR20210311005Enrolling By Invitation3 期
Apixaban level in among Thai patients with non valvular atrial fibrillation
适应症
试验速览
- 阶段
- 3 期
- 状态
- Enrolling By Invitation
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1.Age more than 18 years old
- •2.Patients were diagnosed non valvular AF and received apixaban at least 7 days
- •3.Good adherence 100%
- •4.Patients were signed inform consent
排除标准
- •1.Patients had mechanical valve replacement or moderate to severe mitral stenosis
- •2.Patients diagnosed liver disease with Child Pugh C
- •3.Patient received inappropriate doses of apixaban
- •4.Patients were pregnancy and lactation
- •5.Patients were diagnosed dementia or psychiatric disease
- •6.Patients were required hemodialysis or CAPD
- •7.Patients did not accept catheter insertion for 3 hours
研究者
相似试验
已完成
4 期
The Plasma Level of Branded Generic Apixaban in Patients with Atrial FibrillatioAtrial fibrillation (AF)anti-factorXa activitygeneric apixabanefficiencyAtrial fibrillationTCTR20230410004Faculty of Medicine, Chiang Mai University100
已完成
2 期
Phase II Trial of Apixaban in Japanese Patients with Cancer-Associated Venous Thromboembolismcancer-associated venous thromboemborism (CA-VTE)JPRN-UMIN000028447Kobe University Hospital, Medical Oncology / Hematology62
招募中
Unknown
Investigating the in vivo bioequivalence of Apixaban tabletIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N10Tabriz University of Medical Sciences24
招募中
2 期
Apixaban in heparin-induced thrombocytopeniaIRCT20200325046854N1Iran University of Medical Sciences30
招募中
2 期
Modified Apixaban in Japanese Patients with Cancer-Associated Venous Thromboembolismcancer-associated thromboembolismmalignancy, cancer-associated thromboembolism, CAT, CA-VTEJPRN-jRCTs051220095Minami Hironobu80